Correlation Between Sonoma Pharmaceuticals and Mallinckrodt Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonoma Pharmaceuticals and Mallinckrodt Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonoma Pharmaceuticals and Mallinckrodt Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonoma Pharmaceuticals and Mallinckrodt Plc, you can compare the effects of market volatilities on Sonoma Pharmaceuticals and Mallinckrodt Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonoma Pharmaceuticals with a short position of Mallinckrodt Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonoma Pharmaceuticals and Mallinckrodt Plc.

Diversification Opportunities for Sonoma Pharmaceuticals and Mallinckrodt Plc

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sonoma and Mallinckrodt is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and Mallinckrodt Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mallinckrodt Plc and Sonoma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonoma Pharmaceuticals are associated (or correlated) with Mallinckrodt Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mallinckrodt Plc has no effect on the direction of Sonoma Pharmaceuticals i.e., Sonoma Pharmaceuticals and Mallinckrodt Plc go up and down completely randomly.

Pair Corralation between Sonoma Pharmaceuticals and Mallinckrodt Plc

Given the investment horizon of 90 days Sonoma Pharmaceuticals is expected to generate 1.18 times more return on investment than Mallinckrodt Plc. However, Sonoma Pharmaceuticals is 1.18 times more volatile than Mallinckrodt Plc. It trades about -0.02 of its potential returns per unit of risk. Mallinckrodt Plc is currently generating about -0.74 per unit of risk. If you would invest  2,200  in Sonoma Pharmaceuticals on August 28, 2024 and sell it today you would lose (1,907) from holding Sonoma Pharmaceuticals or give up 86.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.24%
ValuesDaily Returns

Sonoma Pharmaceuticals  vs.  Mallinckrodt Plc

 Performance 
       Timeline  
Sonoma Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sonoma Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Sonoma Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Mallinckrodt Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mallinckrodt Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Mallinckrodt Plc is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Sonoma Pharmaceuticals and Mallinckrodt Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonoma Pharmaceuticals and Mallinckrodt Plc

The main advantage of trading using opposite Sonoma Pharmaceuticals and Mallinckrodt Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonoma Pharmaceuticals position performs unexpectedly, Mallinckrodt Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mallinckrodt Plc will offset losses from the drop in Mallinckrodt Plc's long position.
The idea behind Sonoma Pharmaceuticals and Mallinckrodt Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios